|
Welcome! Whether you are a potential investor in BioCryst Pharmaceuticals or you are already a shareholder, our investor center is the primary source of information about the company. Just choose a topic, or if you have a question, e-mail us.
Recent Releases
Nov 5, 2009
BioCryst Receives First Peramivir Order From U.S. Government
Nov 4, 2009
BioCryst's Partner Shionogi Files for Peramivir Regulatory Approval in Japan
View all releases »
Investor Relations
Rob Bennett, Executive Director of Business Development & Investor Relations
919.859.7910
investorrelations@biocryst.com
Stockholder Services
Questions about stock transfers and lost certificates should be directed to the transfer agent:
American Stock Transfer & Trust Co.
59 Maiden Lane
New York, New York 10038
Phone (718) 921-8247
|
